legal-news
5:25-cv-04177 In re Iovance Biotherapeutics, Inc. Securities Litigation
updateUpdated 1 day ago
25-cv-04177
|
|
Filed
Advertisement
description
Case Summary
This litigation concerns In re Iovance Biotherapeutics, Inc. Securities Litigation. The docket reflects the filing of an amended complaint, indicating the plaintiffs have refined or expanded their allegations. Securities litigation typically involves claims of misrepresentation or fraud related to investment decisions.
Stage
Active litigation
Timeline
1 event
Coverage
1 article
Sources
1
Key Issues
- • Securities fraud
- • Amended complaint
- • Class action potential
- • Corporate disclosures
update What Changed This Week
1 event
1 article
newspaper
pacer
1 day, 17 hours ago
5:25-cv-04177 In re Iovance Biotherapeutics, Inc. Securities Litigation
info
Other
1 day, 17 hours ago
5:25-cv-04177 In re Iovance Biotherapeutics, Inc. Securities Litigation
Advertisement
Case Timeline
1 event
info
Other
April 15, 2026
5:25-cv-04177 In re Iovance Biotherapeutics, Inc. Securities Litigation
In the securities litigation case involving Iovance Biotherapeutics, the plaintiffs filed an amended complaint. This means they revised their original legal claims, potentially adding new information or clarifying their allegations. Amending a complaint is a common step that can strengthen a case or address issues raised by the court or defendants.
Advertisement
show_chart
Coverage Timeline
newspaper
1 article